Lek

Lek is a prominent Slovenian pharmaceutical company and a core member of the Sandoz Group, a global leader in generic and biosimilar medicines. Established in 1946, Lek has evolved from a local manufacturer into a sophisticated international development and production center for complex pharmaceutical products. The company specializes in a broad range of therapeutic areas, including anti-infectives, cardiovascular diseases, and gastrointestinal disorders. Lek is particularly noted for its advanced capabilities in biotechnology, operating one of the most significant biosimilar development centers in the region. With multiple high-tech facilities across Slovenia, the company provides essential manufacturing and R&D support for the global Sandoz portfolio. Lek remains a vital contributor to the Slovenian economy and a key player in increasing global access to affordable, high-quality healthcare.